Solifenacin NOBEL

Medicinal product

(Invented) name

Solifenacin NOBEL

Active substance (s)

Solifenacino sukcinatas

Strength

5 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

G04BD08, Solifenacin

Marketing authorisation holder

UAB Nobel L., Lietuva

Date of authorisation

2024-05-21

Date of renewal

Documents

5443-44_Solifenacin NOBEL.docx

LT-0203 Solifenacin Nobel_Summ+SD+LT apvalga.pdf

5443_pakuotes lapelis_2024-05-21.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

LT/H/0203/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Solifenacino sukcinatas	5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
113692	99811	1099811	lizdinė plokštelė	N30		Receptinis	LT/1/24/5443/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-05-21	Registruotas